EFNA4 Protein (AA 26-171) (Fc Tag)
-
- Target See all EFNA4 Proteins
- EFNA4 (Ephrin A4 (EFNA4))
- Protein Type
- Recombinant
- Protein Characteristics
- AA 26-171
-
Origin
- Human
-
Source
- HEK-293 Cells
- Purification tag / Conjugate
- This EFNA4 protein is labelled with Fc Tag.
- Purpose
- Human Ephrin-A4/EFNA4 Protein
- Sequence
- Leu26-Gly171
- Characteristics
- Recombinant Human Ephrin-A4/EFNA4 Protein is expressed from HEK293 with hFc tag at the C-Terminus.It contains Leu26-Gly171.
- Purity
- > 95 % as determined by Tris-Bis PAGE,> 95 % as determined by HPLC
- Sterility
- 0.22 μm filtered
- Endotoxin Level
- Less than 1EU per μg by the LAL method.
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/mL is recommended. Dissolve the lyophilized protein in distilled water.
- Buffer
- Lyophilized from 0.22μm filtered solution in PBS ( pH 7.4). Normally 8 % trehalose is added as protectant before lyophilization.
- Storage
- -20 °C,-80 °C
- Storage Comment
- -20 to -80°C for 12 months as supplied from date of receipt., -80°C for 3-6 months after reconstitution., 2-8°C for 2-7 days after reconstitution., Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
- Expiry Date
- 12 months
-
- Target
- EFNA4 (Ephrin A4 (EFNA4))
- Alternative Name
- Ephrin-A4 (EFNA4 Products)
- Synonyms
- EFNA4 Protein, EFL-4 Protein, Epl4 Protein, LERK-4 Protein, EFL4 Protein, EPLG4 Protein, LERK4 Protein, ephrin A4 Protein, ephrin-A4 L homeolog Protein, ephrin-A4 Protein, EFNA4 Protein, efna4.L Protein, efna4 Protein, Efna4 Protein
- Background
- Ephrin A4 is one of the ephrin ligand molecules belonging to the tyrosine kinases receptor family. It was originally identified in a T-lymphoma cell line and seen to be expressed in human adult tissue as well as several tumor types. The cytoplasmic pattern of ephrin A4 could identify a subgroup of primary osteosarcoma patients with a high liability for progression, poor prognosis, and inferior response to chemotherapy.
- Molecular Weight
- 43.1 kDa. Due to glycosylation, the protein migrates to 50-60 kDa based on Tris-Bis PAGE result.
- Pathways
- RTK Signaling
-